Studies of glomerular permeability factor (GPF) in focal segmental glomerular sclerosis and the relationship between GPF and vascular permeability factor (VPF)

Clinical Nephrology

Volumn 52, Issue 5, 1999, Pages 278-284

  Kondo, S ^a   Yoshizawa, N ^a   Kusumi, Y ^b   Takeuchi, A ^a   Torikata, C ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Focal segmental glomerular sclerosis (FGS); Glomerular permeability factor (GPF); Minimal change nephrotic syndrome (MCNS); Vascular permeability factor (VPF)

Indexed keywords

CONCANAVALIN A; GLOMERULAR PERMEABILITY FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CHILD; CHRONIC GLOMERULONEPHRITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOCAL GLOMERULOSCLEROSIS; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MALE; MEMBRANE PERMEABILITY; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE GLOMERULONEPHRITIS; MONONUCLEAR CELL; NONHUMAN; RAT;

EID: 0032718301     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Boulton Jones JM, Tulloch J, Dore B, Mclay A 1983 Changes in the glomerular capillary wall induced by lymphocyte products and serum of nephrotic patients. Clin Nephrol 20: 72-77
2. Brown LP, Berse B, Tognazzi K, Manseau EJ, Water L, Senger DR, Dvorak HF 1992 Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int 42: 1457-1461
3. Cheung PK, Pieter AK, Bakker WW 1996 Minimal change-like glomerular alterations induced by a plasma factor. Nephron 74: 586-593
4. Dantal J, Testa A, Bigot E, Soulillou JP 1990 Disappearance of proteinuria after immunoadsorption in a patient with focal glomeralosclerosis. Lancet 336: 190
5. Dantal J, Bigot E, Bogers W, Testa A, Kriaa F, Jacques Y, Hurault B, Niaudet P, Charpentier B, Soulillou JP 1994 Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med 330: 7-14
6. Garin EH, Blanchard DK, Matsushima K, Djeu Y 1994 IL-8 production by peripheral blood mononuclear cells in nephrotic patients. Kidney Int 45: 1311-1317
7. Garin EH 1995 Effect of lipoid nephrosis cytokine on glomerular sulfated compounds and albuminuria. Pediatr Nephrol 9: 587-593
8. Haltia A, Solin ML, Jalanko H, Holmberg C, Miettinen A, Holthofer H 1996 Mechanisms of proteinuria: vascular permeability factor in congenital nephrotic syndrome of the Finnish type. Pediatr Res 40: 652-657
9. Iijima K, Yoshikawa N, Daniel TC, Nakamura H 1993 Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factor. Kidney Int 44: 959-966
10. Koyama A, Fujisaki M, Kobayashi M, Igarashi M, Narita M 1991 A glomerular permeability factor produced by human T cell hybridomas. Kidney Int 40: 453-460
11. Lagrue GA, Xheneumont S, Branellec AI, Hirbec G, Weil B 1975 A vascular permeability factor elaborated from lymphocytes. II. Demonstration in patients with nephrotic syndrome. Biomed 23: 37-40
12. Maruyama K, Tomizawa S, Shimabukuro N, Fukuda T, Johshita T, Kuroume T 1989 Effect of supernatant derived from T lymphocyte culture in minimal change nephrotic syndrome on rat kidney capillaries. Nephron 51: 73-76
13. Mandreoli M, Beltrandi E, Casadei-Maldini M, Mancini R, Zucchelli A, Zucchelli P 1992 Lymphocyte release of soluble IL-2 receptors in patients with minimal change nephropathy. Clin Nephrol 37: 177-182
14. Noguchi K, Yoshikawa N, Ito-kariya S, Inoue Y, Hayashi Y, Ito H, Nakamura H, Ijjima K 1998 Activated mesangial cells produce vascular permeability factor in early-stage mesangial proliferative glomerulonephritis. J Am Soc Nephrol 9: 1815-1825
15. 165 mediates glomerular endothelial cell (GEnC) proliferation but not proteinuria in immune mediated glomerulonephritis. J Am Soc Nephrol 9: 483A (abstract)
16. Ovary Z 1951 A new method for the quantitative determination of anaphylactic antibody in sera of guinea pigs and rabbits. Proc Int Congr Allergy 156: 315
17. Savin VJ, Sharma R, Sharma M, McCarthy ET, Swan SK, Ellis E, Lovell H, Warady B, Gunwar S, Chonko, A, Artero, M, Vincenti F 1996 Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulonephritis. N Engl J Med 334: 878-883
18. Saxena S, Mittal A, Andal A 1993 Pattern of interleukins in minimal-change nephrotic syndrome of childhood. Nephron 65: 56-61
19. Schnaper HW 1990 A regulatory system for soluble immune response suppressor production in steroid-responsive nephrotic syndrome. Kidney Int 38: 151-159
20. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF 1983 Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219: 983-985
21. Sobel AT, Branellec AI, Lagrue GA 1977 Physicochemical characterization of a vascular permeability factor produced by Con A-stimulated human lymphocytes. J Immunol 119: 1230-1234
22. Yoshizawa N, Kusumi Y, Matsumoto K, Oshima S, Takeuchi A, Kawamura O, Kubota T, Kondo S 1989 Studies of a glomerular permeability factor in patients with minimal change nephrotic syndrome. Nephron 51: 370-376